معرفی
Professor Amirali Popat is affiliated with the University of Queensland under the School of Pharmacy and Pharmaceutical Sciences. His research spans Advanced Drug Delivery, Nanomedicine, and Biomaterials, focusing on targeted therapies for brain and prostate cancers, mucosal diseases, and 3D printed pharmaceuticals.
- Education: Master of Pharmaceutical Science (Gujarat University), Bachelor of Pharmacy (Gujarat University)
His work includes surface-modified nanomaterials (e.g., silica, liposomes) for overcoming biological barriers and programmable nanoparticles for oral delivery. Recent articles highlight gene therapy for meningioma, 3D printed tablets for personalized prednisone doses, and CBD-targeted therapies in colorectal cancer.
- Scientific Awards: NHMRC Career Development Fellowship (2018-2021), ARC Industrial Transformation Training Centres Funding (2023-2028), Brain Foundation Research Grant (2024-2025)
He supervises PhD candidates in projects involving nanomedicine for glioblastoma, MgO antimicrobial delivery, and 3D printed dosage forms. Collaborations include teams at UQ's Centre for Extracellular Vesicle Nanomedicine and partnerships with industry and international universities.
